Session speakers are among the PBM, specialty pharmacy, pharma and biotech, and affiliated industries’ top thought leaders and decision makers. The conference sessions will be available to watch “On Demand” with two sessions live streaming from 11 am – 12:45 pm ET on September 14 and 15. All sessions will remain available to view for registered attendees on the virtual conference platform through the end of September.
Additionally, new this year we have added a “sessions-only” registration option, which allows anyone to register to view all conference sessions. For more information contact Jenny Bradham.
6:00 am - 9:00 pm ET | Virtual Meeting Rooms Open | |
On Demand Sessions | Welcome Remarks JC Scott, President & Chief Executive Officer, PCMA Brian McCarthy, Chief Strategy and Business Operations Officer, PCMA
The Long Game Strategy for Transforming Pharmacy from Volume to Value – A Call to Action for all Stakeholders Chronis Manolis, Senior Vice President, Pharmacy Services & Chief Pharmacy Officer, UPMC Health Plan View DetailsPharmacy is way behind in the move to value. This session will look at key stakeholders (ie PBMs, payors and pharma) and their leadership role in transforming pharmacy to a value construct. By attending this session you should be able to:
Drug Pricing Reform Efforts: Administration EOs and Political Dynamics Joe Grogan, Former Assistant to President Donald J. Trump and Director of the Domestic Policy Council Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips LLP View DetailsLast month, President Trump signed four drug pricing executive orders (EO’s). These EO’s direct agency action across a host of policy areas, including Part D rebates, Part B reimbursement and pricing, 340B drug discounts, and drug importation. Since the introduction of the Administration EO’s, it has been unclear which specific policies will be advanced or finalized. During this session Joe will share insights and projections about the pandemic, EOs, including the rebate rule, prescription drug pricing and more. | |
LIVE STREAM Sessions 11:00 am - 12:45 pm ET | 11:00 am – 11:45 am ET PBM Industry Priorities (live streaming) Alan Lotvin, Executive Vice President, CVS Health & President, CVS Caremark Ken Paulus. President & Chief Executive Officer, Prime Therapeutics Moderator: JC Scott, President & Chief Executive Officer, PCMA View DetailsPCMA leadership will engage in a dialog covering the most pressing matters of the day including; PBM’s role in confronting the COVID-19 pandemic, aligning the patient centric business objectives of all supply chain partners, and the importance of collaboration between the PBM and biopharmaceutical industries.
12:00 pm – 12:45 pm ET Tracking New Realities Brought on in 2020 (live streaming) Kabir Nath, President & CEO, Otsuka North America Pharmaceutical Business William Fleming, President, Clinical and Pharmacy Solutions, Healthcare Services, Humana Inc. Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips LLP View Details2020 has been a year of unexpected challenges for everyone, especially those delivering health care. There have been three major crisis going on all at the same time – the pandemic, social disparities, and economic unevenness – that has impacted business. Join us as two industry leader’s share their perspectives on the social justice reform, the “new normal” for the healthcare supply chain, changes in behavior health prevalence, as well diagnosis and treatment in the COVID-19 era.
|
6:00 am - 9:00 pm ET | Virtual Meeting Rooms Open | |
On Demand Sessions | Trends, Issues & Outlook during COVID-19 Doug Long, Vice President, Industry Relations, IQVIA View DetailsThis session will explore trends impacting the U.S. pharmaceutical market during COVID-19. Topics addressed will include:
Encouraging a Robust US Biosimilars Marketplace: What’s Best for Payers, Patients and Drug Makers? Sheila Frame, Vice President, Marketing, Market Access and Patient Services, Sandoz Mike Zeglinski, Senior Vice President & Chief Executive Officer, Optum Specialty & Infusion Pharmacies, OptumRx Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips LLP View DetailsWhen we think about rising prescription drug costs, we need to think about biologic drugs. In recent years, startling breakthrough have come to market that give hope to millions who, until now, had no effective treatments for their conditions. At the same time, some of these treatments have arrived with very high prices. The creation of a U.S. pathway for biosimilar drug approval in the Affordable Care Act came with great hopes for bringing competition and savings to the biologic drug market. This panel will discuss where the biosimilar market is and where we are headed. Topics covered in this session will include proposals and incentives to encourage the uptake of biosimilars, reimbursement rates, aspects impacting adoption, and interchangeability.
The Path Forward for Medication Access and Patient-Centered Care (session Sponsored by CoverMyMeds) Kyle Grimslid, Director, Clinical Solutions, CoverMyMeds View DetailsTopics addressed will include:
Learning objectives:
Describe how COVID-19 has further impacted patients with chronic conditions who are prescribed specialty therapies | |
LIVE STREAM Sessions 11:00 am - 12:45 pm ET | 11:00 am – 11:45 am ET Drug Price and Affordability Challenges: Market Solutions and Efforts in Washington (live streaming) Amy Bricker, Senior Vice President, Supply Chain and Drug Procurement, Express Scripts Kent Rogers, Senior Vice President, Chief Formulary & Procurement Officer, Industry Relations, UnitedHealth Group Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips LLP View DetailsTwo of the PBM industry’s top thought leaders and influencers will engage in a discussion on the evolving and dynamic role PBMs play in the drug supply chain as it relates to prescription drug access, affordability, and outcomes.
12:00 pm – 12:45 pm ET Evolving Policy and Business Dynamics of 2020 and 2021 (live streaming) Kate Larkin, Senior Vice President and Head, U.S. Value, Access and Payment, Bristol-Myers Squibb Jamey Millar, Senior Vice President, Managed Markets and Government Affairs, GlaxoSmithKline Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips LLP View DetailsTwo of the biopharmaceutical industry’s top thought leaders and influencers will engage in a discussion on recent policy proposals to address drug affordability and price, alignment opportunities between drug makers, payers, and PBMs, patient affordability and access, and other dynamics impacting the drug supply chain. | |
3:00 pm - 4:00 pm ET | PCMA Diversity & Inclusion Initiative Event View DetailsJoin us for a presentation and discussion that examines current events – the pandemic, economic crisis and social unrest – through the lens of diversity and inclusion and their impact on us as individuals and as an industry. What opportunities do an increasingly diverse workforce, workplace and marketplace bring to our industry? What can we do to be more inclusive? For more than 25 years, Janet Crenshaw Smith, Founder and President of Ivy Planning Group, has worked with the world’s largest organizations to build and execute diversity and inclusion strategies. She has seen what works and what doesn’t. She will share lessons learned and provide authentic advice, evidence-based solutions, and real-world tested approaches to leveraging diversity and inclusion as an opportunity. Following Janet’s remarks, a panel from our industry will share their personal perspectives and experiences on diversity and inclusion. The panel will speak for about 30 minutes.
Opening Remarks by 2020 Co-Chairs Bethanie Stein, Vice President, Supply Chain & Analytics, Humana Christine Marsh, Senior Vice President, Market Access, Boehringer Ingelheim
Diversity, Equity and Inclusion 2020: Opportunities, Lessons Learned and Strategies for Success Janet Smith, President, Ivy Planning Group
Panel Discussion Jonah Houts, Vice President & General Manager, Network Contracting and Strategy, Express Scripts Lilian Ndehi, Director Patient Safety & Pharmacy Stars, Humana Tina Patel, Vice President, Market Access Marketing, Boehringer Ingelheim Moderator: Janet Smith, President, Ivy Planning Group |